FGFR4 and neoplasm: In type 2 SCAs, the expression levels of fibroblast growth factor receptor-4, matrix metalloproteinase-1, and β1-integrin which associates with tumor aggressiveness, are higher than that in type 1 SCAs (45), suggesting different tumor pathologies, however it remains unclear whether these two subtypes indeed influence tumor behavior.